about
Molecular mechanisms of ischemic preconditioning in the kidneyIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesProphylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trialA nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.Effects of long-acting erythropoietin analog darbepoetin-α on adriamycin-induced chronic nephropathy.Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis ratsInternal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS).Managing kidney disease with blood-pressure control.Every allograft needs a silver lining.Erythropoietin and renal protection.Renal tissue pro-inflammatory gene expression is reduced by erythropoietin in rats subjected to hemorrhagic shock.Comment on: Protective Role of Recombinant Human Erythropoietin in Kidney and Lung Injury Following Renal Bilateral Ischemia-reperfusion in Rat Model.
P2860
Q28080772-EE064511-13B1-46A3-B315-5781D866B307Q28388335-EB559056-D0EA-41C2-B80E-E2D39AF9F208Q34800472-3824E6C6-BF7E-44CC-B8AB-7988E01AB203Q35287077-F475F0FD-8859-4970-942F-E66CAE80824FQ35867619-FB4F68B4-E931-4702-BB18-4045E8D35912Q36071692-E35A4371-28AB-4008-8BA5-B518ED1473FEQ36597896-33C8B437-1DBF-4B59-BDC4-46B8E3BB6C58Q37113720-52F872EF-975A-4535-A10F-B2E36CFB1236Q37892340-6269E6DF-E640-4A35-B116-DE78510FD1ECQ40718233-7CF7D389-713D-4725-AB0C-EAF3D7ACBB25Q41845825-BE25DA1D-3F82-4F42-B181-3492AA57476CQ41862165-1BE9EDC6-A9D2-4B64-BBC8-D2B0ABC1C09DQ42861429-C4FB681F-4A33-437F-B3F4-F3CB71A22AF0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
EPO: renoprotection beyond anemia correction.
@ast
EPO: renoprotection beyond anemia correction.
@en
type
label
EPO: renoprotection beyond anemia correction.
@ast
EPO: renoprotection beyond anemia correction.
@en
prefLabel
EPO: renoprotection beyond anemia correction.
@ast
EPO: renoprotection beyond anemia correction.
@en
P1433
P1476
EPO: renoprotection beyond anemia correction.
@en
P2093
Danilo Fliser
Ferdinand H Bahlmann
P2888
P304
P356
10.1007/S00467-006-0284-2
P577
2006-09-07T00:00:00Z